← Open Payments lookup

PETER WEINGOLD: Open Payments

NPI 1740202035 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,227 in 51 payments from 8 companies in 2025. Trend: 2023 $1,390 · 2024 $1,154 · 2025 $1,227

Food & beverage: $1,227
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.11$286
Lundbeck LLC10$257
ABBVIE INC.11$237
Otsuka America Pharmaceutical, Inc.10$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$138
Alkermes, Inc.2$57
Axsome Therapeutics, Inc.1$26
E.R. Squibb & Sons, L.L.C.1$26

Products named: REXULTI, TRINTELLIX, VRAYLAR, CAPLYTA, LYBALVI, Auvelity, COBENFY.

Industry payments across CA — which companies pay providers there.